Immunohistochemical localization of endothelin-1 in human placenta from normal and growth-restricted pregnancies

Pediatric and Developmental Pathology

Volumn 6, Issue 4, 2003, Pages 307-313

  Erdem, Mehmet ^a   Erdem, Ahmet ^a   Erdem, Ozlem ^a   Yildirim, Gizem ^a   Memis, Leyla ^a   Himmetoǧlu, Ozdemir ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Endothelin 1; Immunohistochemistry; Intrauterine growth restriction; Placenta; Umbilical artery Doppler

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; DOPPLER FLOWMETER; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SCORING SYSTEM; TROPHOBLAST; UMBILICAL ARTERY; VASOCONSTRICTION; WAVEFORM;

ADULT; CASE-CONTROL STUDIES; DECIDUA; ENDOTHELIN-1; FEMALE; FETAL GROWTH RETARDATION; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PREGNANCY; TISSUE DISTRIBUTION; TROPHOBLASTS; ULTRASONOGRAPHY, DOPPLER; UMBILICAL ARTERIES;

EID: 0141650396     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-002-0060-7     Document Type: Article

References (24)

1. Piper JM, Xenakis EM, McFarland M, Elliott BD, Berkus MD, Langer O. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants?. Obstet Gynecol 1996;87:169-174.
2. Giles WB, Trudinger BJ, Baird P. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985;92:31-38.
3. McCowan LM, Mullen BM, Ritchie K. Umbilical artery flow velocity waveforms and the placental vascular bed. Am J Obstet Gynecol 1987;157:900-902.
4. Fok RY, Pavlova Z, Benircshke K, Paul RH, Platt LD. The correlation of arterial lesions with umbilical artery Doppler velocimetry in the placentas of small-for-dates pregnancies. Obstet Gynecol 1990;75:578-583.
5. Macara L, Kingdom JCP, Kaufman P. Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996;17:37-48.
6. Inou A, Yanagisawa M, Kimura S. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863-2867.
7. van Papendorp CL, Cameron IT, Davenport AP. Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta. J Endocrinol 1991;131:507-511.
8. Robaut C, Mondon F, Bandet J, Ferre F, Cavero I. Regional distribution and pharmacological characterization of [125I] endothelin-1 binding sites in human fetal placental vessels. Placenta 1991;12:55-67.
9. Wilkes BM, Susin M, Mento PF. Localization of endothelin-1-like immunoreactivity in human placenta. J Histochem Cytochem 1993;41:535-541.
10. Rutherford RA, Wharton J, McCarthy A. Differential localization of endothelin ETA and ETB binding sites in human placenta. Br J Pharmacol 1993;109:544-552.
11. McQueen J, Kingdom JCP, Connell JMC, Whittle MJ. Fetal endothelin levels and placental vascular endothelin receptors in intrauterine growth retardation. Obstet Gynecol 1993;82:992-998.
12. Harvey-Wilkis KB, Nielsen HC, D'Alton ME. Elevated endothelin levels are associated with increased placental resistance. Am J Obstet Gynecol 1996;174:1599-1604.
13. Kohnen G, Mackenzie F, Collett GP. Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies. Placenta 1997;18:173-180.
14. Graf AH, Hütter W, Hacker GW. Localization and distribution of vasoactive neuropeptides in the human placenta. Placenta 1996;17:413-421.
15. Barros JS, Bairos VA, Baptista MG, Fagulha JO. Immunocytochemical localization of endothelin-1 in human placenta from normal and preeclamptic pregnancies. Hypertens Pregn 2001;20:125-137.
16. Campbell S, Vyas S, Nicolaides KHJ. Doppler investigation of the fetal circulation. J Perinat Med 1991;19:21-26.
17. Malassine A, Cronier L, Mondon F, Mignot TM, Ferre F. Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta. Cell Tissue Res 1993;271:491-497.
18. Marinoni E, Picca A, Scucchi L, Cosmi EV, Di Iorio R. Immunohistochemical localization of endothelin-1 in placenta and fetal membranes in term and preterm human pregnancy. Am J Reprod Immunol 1995;34:213-218.
19. de Nucci G, Thomas R, D'Orleans-Juste P. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxin factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
20. Hirata Y, Emori T, Eguchi S. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-1373.
21. Davenport AP, Maguire JJ. Is endothelin-induced vasocontriction mediated only by ETA receptors in humans. Trends Pharmacol Sci 1994;15:9-11.
22. Neerhof MG, Silver RK, Caplan MS, Thaete LG. Endothelin-1-induced placental and fetal growth restriction in the rat. J Matern Fetal Med 1997;6:125-128.
23. Thaete LG, Neerhof MG, Silver RK. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig 2001;8:18-23.
24. Alfirevic Z, Neilson JP. Doppler ultrasonography in high risk pregnancies; systemic review with meta-analysis. Am J Obstet Gynecol 1995;172:1379-1387.